Skip to main content
Porto

PMMNG logo

  • Home
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
    • Upcoming Events
    • Archived Myeloma Events
  • Our Members
  • Miles for Myeloma
  • Diversity & Inclusion
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Archived Events
  • IMF: Patient & Family Webinar - From Best of ASH 2021 to 2022 COVID-19 Guidance
  • MMRF: Patient Summit
  • CancerCare: Coping with the Stresses of Caregiving When Your Loved One Has Multiple Myeloma
  • CancerCare: COVID-19, Omicron & Delta Variants, COVID-19 Vaccines & Booster Vaccines - Revised Guidelines for People Living with Cancer and Their Loved Ones
  • Myeloma Crowd: Looking Forward in 2022 for Multiple Myeloma with Robert Orlowski
  • CancerCare: What’s New in Diagnostic Technologies for People Living with Blood Cancers
  • Special PMMNG Meeting: Using Your Patient Data to Inform Treatment Decisions - Conversations with the MMRF and Health Tree Foundation
  • MMRF: Patient Summit
  • CancerCare: Progress in the Treatment of Multiple Myeloma
  • CancerCare: Update from the 2021 American Society of Hematology (ASH) Annual Meeting

MMRF: Expert Session - Myeloma Precursor Disease

MMRF logoWhat:  Webcast video (2:00:06) and slides
When: Wednesday, August 18th 11:00 AM - 1:00 PM (ET)
Where: Web

View webcast video  Access slides

Tags
event
archived
webcast
mmrf
precursor disease
mgus
smoldering myeloma
treatment
clinical trials
monoclonal gammopathy of undetermined significance
Dr. Irene Ghobrial
Dr. Elizabet E. Manasanch